Skip to content
Wearables & measurementTrial meta-analysis3 min read

Activity-tracker programs added about 2123 steps a day in people with chronic disease

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:Can consumer wearable activity tracker-based interventions improve physical activity and cardiometabolic health in patients with chronic diseases? A systematic review and meta-analysis of randomised controlled trials. · The international journal of behavioral nutrition and physical activity · 2020 · Original paper ↗

Key takeaway

Pooling 35 randomised trials, programs built around consumer activity trackers raised physical activity by 2123 steps per day (95% CI 1605-2641) and modestly lowered systolic blood pressure, waist circumference and LDL cholesterol. The programs mostly included counselling, and the abstract does not say how much the tracker itself contributed.

Study design

Trial meta-analysis

Reading basis

Published abstract

Reading focus

Design & applicability

The research question

Consumer activity trackers are popular, but it was unclear whether tracker-based programs help people with chronic disease be more active and improve their health in daily life. The authors pooled randomised trials to test the effect on physical activity and cardiometabolic health.

Who and how

Systematic review and meta-analysis of randomised controlled trials. Five databases (PubMed, Embase, Web of Science, Cochrane Central Register of Controlled Trials and CINAHL) yielded 8147 records after deduplication, of which 35 studies were included. They compared a tracker-based counselling intervention with a control in people with chronic respiratory diseases (7 studies), type 2 diabetes (12), cardiovascular diseases (6), overweight/obesity (3), cognitive disorders (1) or sedentary older adults (6). Data were pooled with a random-effects model.

What it found

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Physical activity rose by 2123 steps per day compared with controls (95% CI 1605-2641; P < 0.001).
  2. 2
    Systolic blood pressure fell by 3.79 mm Hg (95% CI -4.53 to -3.04; P < 0.001).
  3. 3
    Waist circumference fell by 0.99 cm (95% CI -1.48 to -0.50; P < 0.001).
  4. 4
    LDL cholesterol fell by 5.70 mg/dl (95% CI -9.24 to -2.15; P = 0.002).

Limits & uncertainty

  1. 1
    Interventions included counselling or behavioural components, so the benefit cannot be credited to the wearable alone.
  2. 2
    Populations ranged from 12 type 2 diabetes studies down to a single cognitive disorder study, so evidence is uneven across conditions.
  3. 3
    The abstract does not report heterogeneity, trial quality, or how long benefits lasted.
  4. 4
    This reading is based on the abstract only.

What to take from it

Using a tracker as part of a structured program was linked to meaningfully more daily steps, and small improvements in blood pressure and cholesterol, in people with chronic conditions. These blood pressure and cholesterol changes are modest, so they complement and do not replace treatment. Anyone with a chronic disease should check with their clinician before changing their activity level.

Reading your own data

Daily step count is exactly what these programs targeted. Wear the same device consistently, note your usual weekly average first, and set goals as increases over that baseline rather than chasing single days.

How to read this evidence

Pooling trials can improve precision, but compare populations, controls, bias and uncertainty. Network rankings include indirect evidence and do not identify a universal best treatment.

Authors’ structured abstract English

The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.

Background

To date, it is unclear if consumer wearable activity trackers (CWATs), with or without behaviour multi-component strategies, effectively improve adherence to physical activity and health outcomes under free living conditions in populations with chronic diseases. Therefore, we systematically evaluated the efficacy of CWAT-based interventions to promote physical activity levels and cardiometabolic health in populations with chronic diseases.

Methods

Randomised controlled trials were collected from five bibliographic databases (PubMed, Embase, Web of Science, The Cochrane Central Register of Controlled Trials and CINAHL). Studies were eligible for inclusion if they evaluated a CWAT-based counselling intervention versus control intervention among patients with chronic respiratory diseases, type 2 diabetes mellitus, cardiovascular diseases, overweight/obesity, cognitive disorders, or sedentary older adults. Data were pooled using a random-effects model.

Results

After deduplication 8147 were identified of which 35 studies met inclusion criteria (chronic respiratory diseases: 7, type 2 diabetes mellitus: 12, cardiovascular diseases: 6, overweight/obesity: 3, cognitive disorders: 1, sedentary older adults: 6). Compared to control groups, CWAT-based interventions significantly increased physical activity by 2123 steps per day (95% confidence interval [CI], [1605-2641]; p < 0.001). In addition, CWAT-based interventions in these populations significantly decreased systolic blood pressure (- 3.79 mm Hg; 95% CI: [- 4.53, - 3.04] mm Hg; p < 0.001), waist circumference (- 0.99 cm; 95% CI: [- 1.48, - 0.50] cm; p < 0.001) and low-density lipoprotein cholesterol concentration (- 5.70 mg/dl; 95% CI: [- 9.24, - 2.15] mg/dl; p = 0.002).

Conclusion

CWAT-based interventions increase physical activity and have beneficial effects on important health-related outcomes such as systolic blood pressure, waist circumference and LDL cholesterol concentration in patients with chronic diseases.

Sources & attribution

Can consumer wearable activity tracker-based interventions improve physical activity and cardiometabolic health in patients with chronic diseases? A systematic review and meta-analysis of randomised controlled trials.

Franssen WMA, Franssen GHLM, Spaas J, Solmi F, Eijnde BO.

The international journal of behavioral nutrition and physical activity · 2020-05-11

DOI: 10.1186/s12966-020-00955-2 ↗PubMed · 32393357 ↗Europe PMC · Recorded licence: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Cohort study

Activity–stroke and heart attack curves differ by accelerometer processing method

Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.

Preventive Medicine

In-depth explainersRead study →
·Validation study/review

Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven

A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.

Forensic Science International

In-depth explainersRead study →
·Overview of reviews

Activity trackers: about 1,800 more steps a day, but small effects on other outcomes

An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.

The Lancet Digital Health

In-depth explainersRead study →
·Validation study/review

Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages

In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.

Sleep

In-depth explainersRead study →
Wearables & measurement →